Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy

• Main Authors: Sreeneeranj Kasichayanula (Author), Sandhya Mandlekar (Author), Vittal Shivva (Author), Maulik Patel (Author), Sandhya Girish (Author)
• פורמט: ספר
• יצא לאור: Wiley, 2022-08-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Abstract Cancer immunotherapy has significantly advanced the treatment paradigm in oncology, with approvals of immuno‐oncology agents for over 16 indications, many of them first line. Checkpoint inhibitors (CPIs) are recognized as an essential backbone for a successful anticancer therapy regimen. Th...